Adjuvant treatment for gastric cancer: too much is not enough

scientific article published on 18 June 2014

Adjuvant treatment for gastric cancer: too much is not enough is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S1470-2045(14)70293-1
P698PubMed publication ID24954804

P2093author name stringDavid H Ilson
P2860cites workChemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junctionQ28215716
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancerQ29619394
Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trialQ34634440
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialQ34634936
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targetsQ35878807
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesisQ36205151
Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancerQ43620764
Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trialQ88132239
P433issue8
P1104number of pages2
P304page(s)788-789
P577publication date2014-06-18
P1433published inLancet Oncology CommissionQ13747613
P1476titleAdjuvant treatment for gastric cancer: too much is not enough
P478volume15

Reverse relations

cites work (P2860)
Q41549417Caragaphenol a induces reactive oxygen species related apoptosis in human gastric cancer cells
Q64917579Cyclin-dependent kinase 7 inhibitor THZ2 inhibits the growth of human gastric cancer in vitro and in vivo.
Q35870886Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy.
Q92669041HIT000218960 promotes gastric cancer cell proliferation and migration through upregulation of HMGA2 expression
Q36375276Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer
Q36309435MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells
Q41097111Tumor MICA status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer

Search more.